Augmedix, Inc.

2024 Q3 Form 10-Q Financial Statement

#000162828024036771 Filed on August 12, 2024

View on sec.gov

Income Statement

Concept 2024 Q3 2024 Q2 2023 Q2

Balance Sheet

Concept 2024 Q3 2024 Q2 2023 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $28.22M $24.55M
YoY Change 14.94% -18.13%
Cash & Equivalents $28.20M $24.55M
Short-Term Investments
Other Short-Term Assets $2.453M $2.086M
YoY Change 17.59% 20.65%
Inventory
Prepaid Expenses
Receivables $9.252M $9.433M
Other Receivables $0.00 $0.00
Total Short-Term Assets $39.93M $36.07M
YoY Change 10.69% -0.94%
LONG-TERM ASSETS
Property, Plant & Equipment $3.333M $2.608M
YoY Change 27.8% 124.25%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $5.983M $1.541M
YoY Change 288.25% 42.82%
Total Long-Term Assets $13.75M $7.778M
YoY Change 76.74% 87.47%
TOTAL ASSETS
Total Short-Term Assets $39.93M $36.07M
Total Long-Term Assets $13.75M $7.778M
Total Assets $53.67M $43.85M
YoY Change 22.4% 8.1%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $881.0K $1.604M
YoY Change -45.07% 1.26%
Accrued Expenses $8.025M $4.812M
YoY Change 66.77% 31.05%
Deferred Revenue $8.902M
YoY Change
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due $5.000M $5.000M
YoY Change 0.0%
Total Short-Term Liabilities $24.00M $21.26M
YoY Change 12.86% 68.59%
LONG-TERM LIABILITIES
Long-Term Debt $15.54M $14.93M
YoY Change 4.07% 0.0%
Other Long-Term Liabilities $360.0K $3.666M
YoY Change -90.18% 97.84%
Total Long-Term Liabilities $360.0K $18.60M
YoY Change -98.06% 10.8%
TOTAL LIABILITIES
Total Short-Term Liabilities $24.00M $21.26M
Total Long-Term Liabilities $360.0K $18.60M
Total Liabilities $43.20M $39.86M
YoY Change 8.38% 35.59%
SHAREHOLDERS EQUITY
Retained Earnings -$159.9M -$136.1M
YoY Change 17.52% 18.2%
Common Stock $5.000K $4.000K
YoY Change 25.0% 0.0%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $10.47M $3.989M
YoY Change
Total Liabilities & Shareholders Equity $53.67M $43.85M
YoY Change 22.4% 8.1%

Cashflow Statement

Concept 2024 Q3 2024 Q2 2023 Q2

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
us-gaap Gross Profit
GrossProfit
9451000 usd
CY2023Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
4760000 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
12360000 usd
CY2024Q2 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
3749000 usd
dei Entity Address City Or Town
EntityAddressCityOrTown
San Francisco
dei Entity Address State Or Province
EntityAddressStateOrProvince
CA
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
94104
dei City Area Code
CityAreaCode
(888)
dei Local Phone Number
LocalPhoneNumber
669-4885
dei Amendment Flag
AmendmentFlag
false
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q2
dei Entity Central Index Key
EntityCentralIndexKey
0001769804
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2024
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2024-06-30
dei Document Transition Report
DocumentTransitionReport
false
dei Entity Registrant Name
EntityRegistrantName
AUGMEDIX, INC.
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
83-3299164
dei Entity Address Address Line1
EntityAddressAddressLine1
111 Sutter Street
dei Entity Address Address Line2
EntityAddressAddressLine2
Suite 1300
dei Trading Symbol
TradingSymbol
AUGX
dei Security Exchange Name
SecurityExchangeName
NASDAQ
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
dei Entity Small Business
EntitySmallBusiness
true
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
true
dei Entity Ex Transition Period
EntityExTransitionPeriod
false
dei Entity Shell Company
EntityShellCompany
false
CY2024Q3 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
49243752 shares
CY2024Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
28220000 usd
CY2023Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
46217000 usd
CY2024Q2 us-gaap Restricted Cash Current
RestrictedCashCurrent
0 usd
CY2023Q4 us-gaap Restricted Cash Current
RestrictedCashCurrent
125000 usd
CY2024Q2 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
204000 usd
CY2023Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
110000 usd
CY2024Q2 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
9252000 usd
CY2023Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
8572000 usd
CY2024Q2 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
2453000 usd
CY2023Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
1909000 usd
CY2024Q2 us-gaap Assets Current
AssetsCurrent
39925000 usd
CY2023Q4 us-gaap Assets Current
AssetsCurrent
56823000 usd
CY2024Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
3333000 usd
CY2023Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
3739000 usd
CY2024Q2 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
4431000 usd
CY2023Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
5220000 usd
CY2024Q2 us-gaap Restricted Cash Noncurrent
RestrictedCashNoncurrent
5207000 usd
CY2023Q4 us-gaap Restricted Cash Noncurrent
RestrictedCashNoncurrent
0 usd
CY2024Q2 augx Deposits Assets And Other Assets Noncurrent
DepositsAssetsAndOtherAssetsNoncurrent
776000 usd
CY2023Q4 augx Deposits Assets And Other Assets Noncurrent
DepositsAssetsAndOtherAssetsNoncurrent
930000 usd
CY2024Q2 us-gaap Assets
Assets
53672000 usd
CY2023Q4 us-gaap Assets
Assets
66712000 usd
CY2023Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
721000 usd
CY2024Q2 augx Accrued Liabilities And Other Liabilities Current
AccruedLiabilitiesAndOtherLiabilitiesCurrent
6929000 usd
CY2023Q4 augx Accrued Liabilities And Other Liabilities Current
AccruedLiabilitiesAndOtherLiabilitiesCurrent
6589000 usd
CY2024Q2 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
8902000 usd
CY2023Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
8963000 usd
CY2024Q2 us-gaap Customer Refund Liability Current
CustomerRefundLiabilityCurrent
851000 usd
CY2023Q4 us-gaap Customer Refund Liability Current
CustomerRefundLiabilityCurrent
851000 usd
CY2024Q2 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
1432000 usd
CY2023Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
1494000 usd
CY2024Q2 us-gaap Loans Payable Current
LoansPayableCurrent
5000000 usd
CY2023Q4 us-gaap Loans Payable Current
LoansPayableCurrent
5000000 usd
CY2024Q2 us-gaap Liabilities Current
LiabilitiesCurrent
23995000 usd
CY2023Q4 us-gaap Liabilities Current
LiabilitiesCurrent
23618000 usd
CY2024Q2 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
3303000 usd
CY2023Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
4049000 usd
CY2024Q2 us-gaap Long Term Loans Payable
LongTermLoansPayable
15540000 usd
CY2024Q2 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
360000 usd
CY2023Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
421000 usd
CY2024Q2 us-gaap Liabilities
Liabilities
43198000 usd
CY2023Q4 us-gaap Liabilities
Liabilities
43391000 usd
CY2024Q2 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2023Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
dei Security12b Title
Security12bTitle
Common Stock, $0.0001 par value per share
CY2024Q2 us-gaap Accounts Payable Current
AccountsPayableCurrent
881000 usd
CY2023Q4 us-gaap Long Term Loans Payable
LongTermLoansPayable
15303000 usd
CY2023Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2024Q2 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2024Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000 shares
CY2023Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000 shares
CY2024Q2 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2024Q2 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2023Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2023Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2024Q2 us-gaap Preferred Stock Value
PreferredStockValue
0 usd
CY2023Q4 us-gaap Preferred Stock Value
PreferredStockValue
0 usd
CY2024Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2023Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2023Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
500000000 shares
CY2024Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
500000000 shares
CY2024Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
49080486 shares
CY2024Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
49080486 shares
CY2023Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
48613714 shares
CY2023Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
48613714 shares
CY2024Q2 us-gaap Common Stock Value
CommonStockValue
5000 usd
CY2023Q4 us-gaap Common Stock Value
CommonStockValue
5000 usd
CY2024Q2 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
171480000 usd
CY2023Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
169197000 usd
CY2024Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-159911000 usd
CY2023Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-144962000 usd
CY2024Q2 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-1100000 usd
CY2023Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-919000 usd
CY2024Q2 us-gaap Stockholders Equity
StockholdersEquity
10474000 usd
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
23321000 usd
CY2024Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
53672000 usd
CY2023Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
66712000 usd
CY2024Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
13664000 usd
CY2023Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
10780000 usd
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
27136000 usd
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
20408000 usd
CY2024Q2 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
7209000 usd
CY2023Q2 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
5715000 usd
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
14340000 usd
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
10957000 usd
CY2024Q2 us-gaap Gross Profit
GrossProfit
6455000 usd
CY2023Q2 us-gaap Gross Profit
GrossProfit
5065000 usd
us-gaap Gross Profit
GrossProfit
12796000 usd
CY2024Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
7013000 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
8967000 usd
CY2023Q2 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
2649000 usd
us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
7313000 usd
us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
5212000 usd
CY2024Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
4418000 usd
CY2023Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
2590000 usd
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
8250000 usd
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
5300000 usd
CY2024Q2 us-gaap Operating Expenses
OperatingExpenses
15180000 usd
CY2023Q2 us-gaap Operating Expenses
OperatingExpenses
9999000 usd
us-gaap Operating Expenses
OperatingExpenses
27923000 usd
us-gaap Operating Expenses
OperatingExpenses
19479000 usd
CY2024Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-8725000 usd
CY2023Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-4934000 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-15127000 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-10028000 usd
CY2024Q2 us-gaap Interest Expense Other
InterestExpenseOther
639000 usd
CY2023Q2 us-gaap Interest Expense Other
InterestExpenseOther
558000 usd
us-gaap Interest Expense Other
InterestExpenseOther
1255000 usd
us-gaap Interest Expense Other
InterestExpenseOther
966000 usd
CY2024Q2 us-gaap Investment Income Interest
InvestmentIncomeInterest
410000 usd
CY2023Q2 us-gaap Investment Income Interest
InvestmentIncomeInterest
276000 usd
us-gaap Investment Income Interest
InvestmentIncomeInterest
913000 usd
us-gaap Investment Income Interest
InvestmentIncomeInterest
438000 usd
CY2024Q2 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
0 usd
CY2023Q2 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
69000 usd
us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
0 usd
us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
69000 usd
CY2024Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
590000 usd
CY2023Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
303000 usd
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
527000 usd
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
437000 usd
CY2024Q2 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
361000 usd
CY2023Q2 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-48000 usd
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
185000 usd
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-160000 usd
CY2024Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-8364000 usd
CY2023Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-4982000 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-14942000 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-10188000 usd
CY2024Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
86000 usd
CY2023Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
51000 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
7000 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
84000 usd
CY2024Q2 us-gaap Net Income Loss
NetIncomeLoss
-8450000 usd
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
-5033000 usd
us-gaap Net Income Loss
NetIncomeLoss
-14949000 usd
us-gaap Net Income Loss
NetIncomeLoss
-10272000 usd
CY2024Q2 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
-194000 usd
CY2023Q2 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
-298000 usd
us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
-181000 usd
us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
-331000 usd
CY2024Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-8644000 usd
CY2023Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-5331000 usd
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-15130000 usd
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-10603000 usd
CY2024Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.16
CY2024Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.16
CY2023Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.12
CY2023Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.12
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.28
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.28
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.25
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.25
CY2024Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
53387349 shares
CY2024Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
53387349 shares
CY2023Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
43607984 shares
CY2023Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
43607984 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
53223008 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
53223008 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
40566425 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
40566425 shares
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
23321000 usd
CY2024Q1 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
59000 usd
CY2024Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
885000 usd
CY2024Q1 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
13000 usd
CY2024Q1 us-gaap Net Income Loss
NetIncomeLoss
-6499000 usd
CY2024Q1 us-gaap Stockholders Equity
StockholdersEquity
17779000 usd
CY2024Q2 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
154000 usd
CY2024Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
1152000 usd
CY2024Q2 augx Adjustments To Additional Paid In Capital Warrant Fair Value
AdjustmentsToAdditionalPaidInCapitalWarrantFairValue
33000 usd
CY2024Q2 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-194000 usd
CY2024Q2 us-gaap Net Income Loss
NetIncomeLoss
-8450000 usd
CY2024Q2 us-gaap Stockholders Equity
StockholdersEquity
10474000 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
1466000 usd
CY2023Q1 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
85000 usd
CY2023Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
533000 usd
CY2023Q1 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-33000 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
-5239000 usd
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
-3188000 usd
CY2023Q2 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
11845000 usd
CY2023Q2 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
93000 usd
CY2023Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
570000 usd
CY2023Q2 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-298000 usd
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
-5033000 usd
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
3989000 usd
us-gaap Net Income Loss
NetIncomeLoss
-14949000 usd
us-gaap Net Income Loss
NetIncomeLoss
-10272000 usd
us-gaap Depreciation
Depreciation
855000 usd
us-gaap Depreciation
Depreciation
541000 usd
us-gaap Share Based Compensation
ShareBasedCompensation
2037000 usd
us-gaap Share Based Compensation
ShareBasedCompensation
1098000 usd
us-gaap Paid In Kind Interest
PaidInKindInterest
390000 usd
us-gaap Paid In Kind Interest
PaidInKindInterest
255000 usd
us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
-49000 usd
us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
0 usd
us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
0 usd
us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
69000 usd
augx Noncash Lease Expense
NoncashLeaseExpense
601000 usd
augx Noncash Lease Expense
NoncashLeaseExpense
437000 usd
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
188000 usd
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
26000 usd
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
868000 usd
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
3105000 usd
us-gaap Increase Decrease In Prepaid Expenses Other
IncreaseDecreaseInPrepaidExpensesOther
549000 usd
us-gaap Increase Decrease In Prepaid Expenses Other
IncreaseDecreaseInPrepaidExpensesOther
250000 usd
us-gaap Increase Decrease In Deposits Outstanding
IncreaseDecreaseInDepositsOutstanding
-81000 usd
us-gaap Increase Decrease In Deposits Outstanding
IncreaseDecreaseInDepositsOutstanding
442000 usd
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
399000 usd
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-102000 usd
us-gaap Increase Decrease In Accrued Liabilities And Other Operating Liabilities
IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities
399000 usd
us-gaap Increase Decrease In Accrued Liabilities And Other Operating Liabilities
IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities
-567000 usd
us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
-61000 usd
us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
604000 usd
augx Increase Decrease In Refundable Customer Deposits
IncreaseDecreaseInRefundableCustomerDeposits
0 usd
augx Increase Decrease In Refundable Customer Deposits
IncreaseDecreaseInRefundableCustomerDeposits
-38000 usd
us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
-617000 usd
us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
-429000 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-12045000 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-12175000 usd
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
930000 usd
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
1475000 usd
us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
27000 usd
us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
0 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-903000 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-1475000 usd
us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
0 usd
us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
5000000 usd
us-gaap Payments Of Financing Costs
PaymentsOfFinancingCosts
80000 usd
us-gaap Payments Of Financing Costs
PaymentsOfFinancingCosts
55000 usd
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
0 usd
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
11845000 usd
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
213000 usd
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
179000 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
133000 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
16969000 usd
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
-100000 usd
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
-47000 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-12915000 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
3272000 usd
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
46342000 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
21988000 usd
CY2024Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
33427000 usd
CY2023Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
25260000 usd
us-gaap Interest Paid Net
InterestPaidNet
864000 usd
us-gaap Interest Paid Net
InterestPaidNet
667000 usd
us-gaap Income Taxes Paid
IncomeTaxesPaid
56000 usd
us-gaap Income Taxes Paid
IncomeTaxesPaid
8000 usd
us-gaap Operating Lease Payments
OperatingLeasePayments
716000 usd
us-gaap Operating Lease Payments
OperatingLeasePayments
485000 usd
us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
289000 usd
us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
155000 usd
us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
0 usd
us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
2498000 usd
augx Fair Value Of Warrants Issued In Connection With Loan
FairValueOfWarrantsIssuedInConnectionWithLoan
0 usd
augx Fair Value Of Warrants Issued In Connection With Loan
FairValueOfWarrantsIssuedInConnectionWithLoan
492000 usd
augx Change In Fair Value Of Warrants Issued In Connection With Loan Amendment
ChangeInFairValueOfWarrantsIssuedInConnectionWithLoanAmendment
33000 usd
augx Change In Fair Value Of Warrants Issued In Connection With Loan Amendment
ChangeInFairValueOfWarrantsIssuedInConnectionWithLoanAmendment
0 usd
CY2024Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
28220000 usd
CY2023Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
24551000 usd
CY2024Q2 us-gaap Restricted Cash Current
RestrictedCashCurrent
0 usd
CY2023Q2 us-gaap Restricted Cash Current
RestrictedCashCurrent
125000 usd
CY2024Q2 us-gaap Restricted Cash Noncurrent
RestrictedCashNoncurrent
5207000 usd
CY2023Q2 us-gaap Restricted Cash Noncurrent
RestrictedCashNoncurrent
584000 usd
CY2024Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
33427000 usd
CY2023Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
25260000 usd
CY2024Q2 augx Number Of Worldwide Office Locations
NumberOfWorldwideOfficeLocations
3 country
CY2023Q2 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
11800000 usd
CY2023Q2 us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
191000 usd
CY2023Q4 us-gaap Stock Issued During Period Shares New Issues
StockIssuedDuringPeriodSharesNewIssues
7187500 shares
CY2023Q4 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
26300000 usd
CY2023Q4 us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
2500000 usd
CY2024Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
28200000 usd
augx Incremental Capital Amount
IncrementalCapitalAmount
5000000.0 usd
CY2024Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-159900000 usd
us-gaap Use Of Estimates
UseOfEstimates
<div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Open Sans',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Use of Estimates</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Open Sans',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The preparation of the unaudited interim condensed consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, disclosure of contingent assets and liabilities at the date of the unaudited interim condensed consolidated financial statements and reported amounts of revenue and expenses during the reporting period. The Company’s significant estimates and judgments relate to the incremental borrowing rate used to measure operating lease liabilities and right of use assets, and stock-based compensation, including expected volatility used to measure the fair value of stock options and stock appreciation rights. Actual results could differ from those estimates.</span></div>
CY2024Q2 augx Government Grant Income
GovernmentGrantIncome
431000 usd
CY2023Q2 augx Government Grant Income
GovernmentGrantIncome
78000 usd
augx Government Grant Income
GovernmentGrantIncome
431000 usd
augx Government Grant Income
GovernmentGrantIncome
78000 usd
CY2024Q2 us-gaap Advertising Expense
AdvertisingExpense
319000 usd
CY2023Q2 us-gaap Advertising Expense
AdvertisingExpense
210000 usd
us-gaap Advertising Expense
AdvertisingExpense
583000 usd
us-gaap Advertising Expense
AdvertisingExpense
428000 usd
augx Revenue Performance Obligation Initial Term Timing
RevenuePerformanceObligationInitialTermTiming
P1Y
CY2023Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
8963000 usd
CY2022Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
7254000 usd
augx Contract With Customer Liability Increase In Deferred Revenue
ContractWithCustomerLiabilityIncreaseInDeferredRevenue
23687000 usd
CY2023 augx Contract With Customer Liability Increase In Deferred Revenue
ContractWithCustomerLiabilityIncreaseInDeferredRevenue
42846000 usd
augx Contract With Customer Liability Revenue Recognized Including Opening Balance
ContractWithCustomerLiabilityRevenueRecognizedIncludingOpeningBalance
23748000 usd
CY2023 augx Contract With Customer Liability Revenue Recognized Including Opening Balance
ContractWithCustomerLiabilityRevenueRecognizedIncludingOpeningBalance
41137000 usd
CY2024Q2 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
8902000 usd
CY2023Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
8963000 usd
CY2024Q2 us-gaap Capitalized Contract Cost Amortization
CapitalizedContractCostAmortization
171000 usd
CY2023Q2 us-gaap Capitalized Contract Cost Amortization
CapitalizedContractCostAmortization
215000 usd
us-gaap Capitalized Contract Cost Amortization
CapitalizedContractCostAmortization
308000 usd
us-gaap Capitalized Contract Cost Amortization
CapitalizedContractCostAmortization
372000 usd
CY2024Q2 us-gaap Capitalized Contract Cost Net Current
CapitalizedContractCostNetCurrent
441000 usd
CY2023Q4 us-gaap Capitalized Contract Cost Net Current
CapitalizedContractCostNetCurrent
494000 usd
CY2024Q2 us-gaap Capitalized Contract Cost Net Noncurrent
CapitalizedContractCostNetNoncurrent
103000 usd
CY2023Q4 us-gaap Capitalized Contract Cost Net Noncurrent
CapitalizedContractCostNetNoncurrent
153000 usd
CY2024Q2 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
7054000 usd
CY2023Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
7230000 usd
CY2024Q2 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
3720000 usd
CY2023Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
3491000 usd
CY2024Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
3333000 usd
CY2023Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
3739000 usd
CY2024Q2 us-gaap Depreciation
Depreciation
416000 usd
CY2023Q2 us-gaap Depreciation
Depreciation
262000 usd
us-gaap Depreciation
Depreciation
855000 usd
us-gaap Depreciation
Depreciation
541000 usd
CY2024Q2 us-gaap Gain Loss On Disposition Of Assets1
GainLossOnDispositionOfAssets1
6000 usd
us-gaap Gain Loss On Disposition Of Assets1
GainLossOnDispositionOfAssets1
-49000 usd
us-gaap Gain Loss On Disposition Of Assets1
GainLossOnDispositionOfAssets1
0 usd
CY2023Q2 us-gaap Gain Loss On Disposition Of Assets1
GainLossOnDispositionOfAssets1
0 usd
CY2024Q2 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
2440000 usd
CY2023Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
3860000 usd
CY2024Q2 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
1570000 usd
CY2023Q4 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
138000 usd
CY2024Q2 augx Accrued Vendor Partner Liabilities Current
AccruedVendorPartnerLiabilitiesCurrent
1290000 usd
CY2023Q4 augx Accrued Vendor Partner Liabilities Current
AccruedVendorPartnerLiabilitiesCurrent
1285000 usd
CY2024Q2 augx Accrued Vat And Other Taxes Current
AccruedVATAndOtherTaxesCurrent
336000 usd
CY2023Q4 augx Accrued Vat And Other Taxes Current
AccruedVATAndOtherTaxesCurrent
393000 usd
CY2024Q2 us-gaap Contract With Customer Refund Liability Current
ContractWithCustomerRefundLiabilityCurrent
199000 usd
CY2023Q4 us-gaap Contract With Customer Refund Liability Current
ContractWithCustomerRefundLiabilityCurrent
198000 usd
CY2024Q2 us-gaap Interest Payable Current
InterestPayableCurrent
142000 usd
CY2023Q4 us-gaap Interest Payable Current
InterestPayableCurrent
146000 usd
CY2024Q2 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
952000 usd
CY2023Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
569000 usd
CY2024Q2 augx Accrued Liabilities And Other Liabilities Current
AccruedLiabilitiesAndOtherLiabilitiesCurrent
6929000 usd
CY2023Q4 augx Accrued Liabilities And Other Liabilities Current
AccruedLiabilitiesAndOtherLiabilitiesCurrent
6589000 usd
CY2024Q2 us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
151000 usd
CY2023Q2 us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
126000 usd
us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
300000 usd
us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
225000 usd
CY2024Q2 us-gaap Operating Lease Cost
OperatingLeaseCost
406000 usd
CY2023Q2 us-gaap Operating Lease Cost
OperatingLeaseCost
336000 usd
us-gaap Operating Lease Cost
OperatingLeaseCost
816000 usd
us-gaap Operating Lease Cost
OperatingLeaseCost
546000 usd
CY2024Q2 us-gaap Short Term Lease Cost
ShortTermLeaseCost
15000 usd
CY2023Q2 us-gaap Short Term Lease Cost
ShortTermLeaseCost
91000 usd
us-gaap Short Term Lease Cost
ShortTermLeaseCost
68000 usd
us-gaap Short Term Lease Cost
ShortTermLeaseCost
175000 usd
CY2024Q2 us-gaap Lease Cost
LeaseCost
421000 usd
CY2023Q2 us-gaap Lease Cost
LeaseCost
427000 usd
us-gaap Lease Cost
LeaseCost
884000 usd
us-gaap Lease Cost
LeaseCost
721000 usd
CY2024Q2 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P3Y6M
CY2023Q4 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P4Y
CY2024Q2 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.083
CY2023Q4 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.083
CY2024Q2 us-gaap Lessee Operating Lease Liability Payments Remainder Of Fiscal Year
LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
686000 usd
CY2024Q2 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
1636000 usd
CY2024Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
1695000 usd
CY2024Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
1021000 usd
CY2024Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
459000 usd
CY2024Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Five
LesseeOperatingLeaseLiabilityPaymentsDueYearFive
10000 usd
CY2024Q2 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
5507000 usd
CY2024Q2 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
773000 usd
CY2024Q2 us-gaap Operating Lease Liability
OperatingLeaseLiability
4734000 usd
CY2024Q2 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
1432000 usd
CY2024Q2 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
3303000 usd
CY2024Q2 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
8478540 shares
CY2024Q2 us-gaap Net Income Loss
NetIncomeLoss
-8450000 usd
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
-5033000 usd
us-gaap Net Income Loss
NetIncomeLoss
-14949000 usd
us-gaap Net Income Loss
NetIncomeLoss
-10272000 usd
CY2024Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
53387349 shares
CY2024Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
53387349 shares
CY2023Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
43607984 shares
CY2023Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
43607984 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
53223008 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
53223008 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
40566425 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
40566425 shares
CY2024Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.16
CY2024Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.16
CY2023Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.12
CY2023Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.12
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.28
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.28
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.25
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.25
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
15308343 shares
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
14569242 shares
us-gaap Defined Contribution Plan Employer Matching Contribution Percent Of Match
DefinedContributionPlanEmployerMatchingContributionPercentOfMatch
0.25
us-gaap Defined Contribution Plan Employer Matching Contribution Percent
DefinedContributionPlanEmployerMatchingContributionPercent
0.04
augx Defined Contribution Plan Service Vesting Period
DefinedContributionPlanServiceVestingPeriod
P1Y
augx Defined Contribution Plan Cash Benefit Eligibility Years Of Service Completed
DefinedContributionPlanCashBenefitEligibilityYearsOfServiceCompleted
P5Y
CY2024Q2 us-gaap Defined Contribution Plan Cost Recognized
DefinedContributionPlanCostRecognized
107000 usd
CY2023Q2 us-gaap Defined Contribution Plan Cost Recognized
DefinedContributionPlanCostRecognized
77000 usd
us-gaap Defined Contribution Plan Cost Recognized
DefinedContributionPlanCostRecognized
234000 usd
us-gaap Defined Contribution Plan Cost Recognized
DefinedContributionPlanCostRecognized
201000 usd
CY2024Q2 augx Defined Contribution Plan Gratuity Fund Liability
DefinedContributionPlanGratuityFundLiability
361000 usd
CY2023Q4 augx Defined Contribution Plan Gratuity Fund Liability
DefinedContributionPlanGratuityFundLiability
421000 usd
CY2024Q2 us-gaap Assets Fair Value Disclosure
AssetsFairValueDisclosure
25339000 usd
CY2024Q2 us-gaap Loans Payable Fair Value Disclosure
LoansPayableFairValueDisclosure
20540000 usd
CY2024Q2 us-gaap Liabilities Fair Value Disclosure
LiabilitiesFairValueDisclosure
20540000 usd
CY2023Q4 us-gaap Assets Fair Value Disclosure
AssetsFairValueDisclosure
43104000 usd
CY2023Q4 us-gaap Loans Payable Fair Value Disclosure
LoansPayableFairValueDisclosure
20303000 usd
CY2023Q4 us-gaap Liabilities Fair Value Disclosure
LiabilitiesFairValueDisclosure
20303000 usd
CY2024Q2 ecd Non Rule10b51 Arr Adopted Flag
NonRule10b51ArrAdoptedFlag
false
CY2024Q2 ecd Rule10b51 Arr Adopted Flag
Rule10b51ArrAdoptedFlag
false
CY2024Q2 ecd Rule10b51 Arr Trmntd Flag
Rule10b51ArrTrmntdFlag
false
CY2024Q2 ecd Non Rule10b51 Arr Trmntd Flag
NonRule10b51ArrTrmntdFlag
false

Files In Submission

Name View Source Status
0001628280-24-036771-index-headers.html Edgar Link pending
0001628280-24-036771-index.html Edgar Link pending
0001628280-24-036771.txt Edgar Link pending
0001628280-24-036771-xbrl.zip Edgar Link pending
augx-20240630.htm Edgar Link pending
augx-20240630.xsd Edgar Link pending
augx-20240630xexx311.htm Edgar Link pending
augx-20240630xexx312.htm Edgar Link pending
augx-20240630xexx321.htm Edgar Link pending
augx-20240630xexx322.htm Edgar Link pending
exhibit104_votingsupportag.htm Edgar Link pending
exhibit105_votingsupportag.htm Edgar Link pending
exhibit106_votingsupportag.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
augx-20240630_def.xml Edgar Link unprocessable
augx-20240630_lab.xml Edgar Link unprocessable
augx-20240630_pre.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
augx-20240630_htm.xml Edgar Link completed
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
augx-20240630_cal.xml Edgar Link unprocessable